Niki BioSolutions, Inc. (NIKI) Convertible Debt (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Convertible Debt came in at $1.3 million in Q4 2025, up 11.57% on a QoQ basis from $1.1 million in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Convertible Debt (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 6 years of Convertible Debt data on file, last reported at $1.3 million in Q4 2025.

Quarterly Convertible Debt changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, up 5.56% from the prior year.
Convertible Debt grew to $1.3 million in Q4 2025, from $1.1 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $3.1 million in Q4 2023 to a low of $614182.0 in Q2 2024.
A 3-year average of $1.4 million and a median of $1.1 million in 2025 frame the typical range for Convertible Debt.
The widest YoY moves for Convertible Debt: up 55.92% in 2025, down 55.92% in 2025.
Tracing NIKI's Convertible Debt over 3 years: stood at $3.1 million in 2023, then tumbled by 79.92% to $614182.0 in 2024, then jumped by 103.87% to $1.3 million in 2025.
The last three Convertible Debt figures came in at $1.3 million (Q4 2025), $1.1 million (Q3 2025), and $957662.0 (Q2 2025), per Business Quant data.

Download Data